FDA Inspection 1180556 — Infectious Diseases Diagnostic Lab
The FDA completed an inspection of Infectious Diseases Diagnostic Lab on Aug 30, 2022 in Minneapolis, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 30, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Minneapolis, MN (United States)